| ²é¿´: 336 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
fenweikingгæ (³õÈëÎÄ̳)
|
[½»Á÷]
¡¾ÇóÖú¡¿Ê²Ã´ÊÇ¿¹Ô³ÊµÝ ÒÑÓÐ2È˲ÎÓë
|
||
|
¿¹Ô³ÊµÝÊÇʲôÒâ˼£¿ Tϸ°û¿¹Ô³ÊµÝµÄ¹ý³ÌÊÇʲô£¿ ΪʲôÐèÒª¿¹Ô³ÊµÝ£¿ лл£¡ |
» ²ÂÄãϲ»¶
ҽѧ¡°²¡Àý¿ì±¨¡±Õ÷¸å
ÒѾÓÐ0È˻ظ´
ÉúÐÅÓѺÃÔÓÖ¾ÍÆ¼ö---Frontiers in Genetics
ÒѾÓÐ0È˻ظ´
Ó°ÏñҽѧÓëÉúÎïҽѧ¹¤³ÌÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ207È˻ظ´
ÈçºÎÔÚÂÛÎÄÖÐÕýȷʹÓà Et Al.
ÒѾÓÐ2È˻ظ´
ѧÊõд×÷ÈçºÎ½øÐÐÓÐЧµÄ¹ý¶É£¨Transitions£© £¿
ÒѾÓÐ0È˻ظ´
ѧÊõÂ۾ݵĽṹӦ¸ÃÈçºÎ׫д
ÒѾÓÐ2È˻ظ´
26Ä격ʿÉêÇë
ÒѾÓÐ12È˻ظ´
26Ä꿼ÑÐ
ÒѾÓÐ12È˻ظ´
3Â¥2010-04-06 20:10:12
| ±í´ïÓÚ¾ÞÊÉϸ°û±íÃæµÄ¶àëÄ-MHC-¢ò·Ö×Ó¸´ºÏÎï±»³ÊµÝ¸øTHϸ°û¡£¹©TcRʶ±ðµÄÏȾöÌõ¼þÊÇÁ½ÖÖϸ°ûµÄÖ±½Ó½Ó´¥²¢Ï໥×÷Óá£ÕâÖÖϸ°û¼äµÄÏ໥×÷ÓÃÉæ¼°APCÓëTH±íÃæ¶àÖÖ·Ö×Ó¡£³ýÁËTcRÌØÒìÐÔµØÍ¬Ê±Ê¶±ð¶àëÄ-MHC-¢ò·Ö×ӵĸ´ºÏÎïÍ⣬ijЩճ¸½·Ö×ÓÒ²²ÎÓ뿹Գʵݹý³Ì¡£ÀýÈçTH±íÃæµÄÁܰÍϸ°û¹¦ÄÜÏà¹Ø¿¹Ô1(lymphocytefunctiom-associated antigen-1,LFA-1)¡¢CD2ºÍCD4·Ö×Ó¿É·Ö±ðÓëAPC±íÃæµÄϸ°û¼äÕ³¸½·Ö×Ó1£¨ICAM-1£©¡¢ÁܰÍϸ°û¹¦ÄÜÏà¹Ø¿¹Ô3£¨LFA-3£©ºÍMHC·Ö×ÓÐγɹ²éîÎ²¢´Ù½øTcRÓë¶àëÄ-MHC·Ö×Ó¸´ºÏÎïµÄÏ໥×÷ÓᣴËÍ⣬ÔÚTcR¦Á¦ÂÁ´Ê¶±ð¿¹Ô¹ý³ÌÖУ¬THϸ°û±íÃæµÄCD3·Ö×Ó²ÎÓë´Ì¼¤ÐźŵĴ«µÝ²¢½éµ¼Tϸ°û²úÉúÁܰÍÒò×Ó¼°·¢»ÓЧӦ¹¦ÄÜ¡£ |
2Â¥2010-04-06 20:09:18














»Ø¸´´ËÂ¥